Beta Drugs 52-Week High & Low
Beta Drugs 52-week high & low stock price. Beta Drugs (BETA) 52-week high ₹2,668.30 (Aug. 11, 2026), 52-week low ₹1,030.30 (Feb. 25, 2026), current price ₹2,004.00 — 24.9% below 52-week high, 94.5% above 52-week low, range position 59.4% (Mid Range). See Beta Drugs P/B valuation to compare market price against book value per share.
52-Week High
₹2,668.30
August 11, 2026
24.9% below high
52-Week Low
₹1,030.30
February 25, 2026
94.5% above low
Current Position in 52-Week Range
52W Low
59.4%
52W High
1638.00
Range Span (₹)
Mid Range
Position Category
59.4%
Range Position
Beta Drugs 52-Week Price Chart
BETA daily price over 52 weeks — current ₹2,004.00, high ₹2,668.30, low ₹1,030.30, range span ₹1638.00. For full fundamentals, ratios and live price, see BETA screener.
Beta Drugs Historical 52-Week High & Low Ranges
BETA annual 52-week high, 52-week low and range span — 2 years of data.
2026
52-Week Range
H: ₹2,668.30
L: ₹1,030.30
159.0% Range
2025
52-Week Range
H: ₹1,743.60
L: ₹1,512.80
15.3% Range
BETA vs Healthcare Sector — 52-Week Range Position & Return
Beta Drugs 52-week range position 59.4% vs Healthcare sector average 115.8%, avg 52-week return 73.6% — 7 peers.
115.8%
Sector Avg Position
73.6%
Sector Avg Return
7
Companies
Syngene Internation…
Position: 184.4% (Near High)
52W Return: 88.4%
Biocon
Position: 133.1% (Near High)
52W Return: 32.7%
SMS Lifesciences
Position: 109.7% (Near High)
52W Return: 75.0%
Aurobindo Pharma
Position: 99.1% (Near High)
52W Return: 63.1%
Sai Life Sciences
Position: 97.6% (Near High)
52W Return: 116.5%
Divis Laboratories
Position: 97.2% (Near High)
52W Return: 72.8%
Emcure Pharmaceutic…
Position: 89.2% (Near High)
52W Return: 66.7%
Volume Analysis at Extremes
High Volume: 100,763
(4.27x avg) - Strong buying interest at high - possible continuation
Low Volume: 28,458
(1.21x avg) - Normal volume at low - typical activity
Average Volume: 23,585